Anlon Healthcare

Anlon Healthcare Net Margin

The Net Profit Margin of Anlon Healthcare (AHCL.NS) as of Nov 16, 2026 is 16.58 %. In the previous year, Net Profit Margin was 17.06 % — a change of -2.79% (lower).

Net Margin

16.58 %

YoY

-2.79%

Last updated:

Net Profit Margin of Anlon Healthcare is 2026 16.58 % . Net Profit Margin of Anlon Healthcare was 2025 17.06 % . It decreases by -2.79% lower compared to the previous year.

For Anlon Healthcare, the net margin of 16.6% is up versus -0.2% a few years ago.

The Anlon Healthcare Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2022
-0.19 INR
Jan 1, 2023
5.16 INR
Jan 1, 2024
14.50 INR
Jan 1, 2025
17.06 INR
Jan 1, 2026
16.58 INR
The Anlon Healthcare Net Margin history
YEARNet MarginYoY
16.58 %-2.79%
17.06 %+17.61%
14.50 %+181.30%
5.16 %-2,835.65%
-0.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Anlon Healthcare Stock analysis

What does Anlon Healthcare do? Anlon Healthcare Ltd. generates revenue through the production and sale of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), nutraceutical APIs, and ingredients for personal care and veterinary applications. Its product portfolio includes 3-(1-cyanoethyl) benzoic acid (CEBA), ketoprofen ethyl ester (KEE), Dex-Ketoprofen, Loxoprofen Acid, Ketoprofen, Silodosin, Omeprazole, L-Arginine, Piroctone olamine, Ticagrelor, and other specialized compounds. The company targets pharmaceutical manufacturers, nutraceutical producers, and personal care and veterinary product developers as its primary customers, serving the broader healthcare and wellness industry segments. The business model focuses on supplying high-quality chemical compounds used in the formulation of medicines and health-related products. Anlon Healthcare Ltd. leverages its expertise in chemical synthesis to deliver tailored solutions for clients in the pharmaceutical sector, ensuring compliance with industry standards. Its product range supports diverse applications, from human medicine to veterinary care and personal care products, enabling it to serve multiple market segments with a single production infrastructure. Revenue streams are derived from direct sales of its chemical products to manufacturers across pharmaceutical, nutraceutical, personal care, and veterinary industries. The company's offerings are designed to meet the specific needs of these sectors, with products like Omeprazole for gastrointestinal treatments and Ticagrelor for cardiovascular care. By providing essential raw materials, Anlon Healthcare Ltd. positions itself as a critical supplier within the healthcare supply chain. Anlon Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Anlon Healthcare stock

Net Profit Margin of Anlon Healthcare is 16.58 % in 2026.

Net Profit Margin of Anlon Healthcare changed from 17.06 % to 16.58 %, representing a -2.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Anlon Healthcare since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Anlon Healthcare with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Anlon Healthcare

All Key Metrics — Anlon Healthcare